| Tag | Content |
|---|
EnhancerAtlas ID | HS072-00715 |
Organism | Homo sapiens |
Tissue/cell | GM19193 |
Coordinate | chr16:28934780-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 | | Tcf12 | MA0521.1 | chr16:28934982-28934993 | CAGCAGCTGTT | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TAGGACACAC CTGGCTTTTC TTATATAGTA GATATAACAA GTTTCCCTTA ATAAATGTAT 60
GTAAACTTTT AAAATGTGGA TCTATTTAAA GAACAAATAT TAAGTAAACA GCACAGTAAG 120
TTGTACAAGG ATGTGTCTAC ATTGCACAGG CAGGTGGATC CTGAAATGTG GGAAATACAG 180
CCCCAGAGAA GTCTCCAGCC ACCAGCAGCT GTTAGAAAGG GAAATCGCAT GTTGGGAAGG 240
GAATTTTAGG AAGTTTACTC TGGAAGCCAA TGTCAAGGCC ACACTATAGA GGAAGATCTG 300
TGAGAAGGTT GGGACAAAAG TCCAGGAGAG AGTTGACGAG AGCCCCACCG CAGCAGGGGC 360
ATAGCAGCGG GGGCAGCTCT GACATCTGTT TCAGAGTCTC TGGCTTCTGC TAGAGGAAGG 420
AGAGTAGAAA ACAGGATCAG CAGCTGGGGC GTCTGGGGCC AGAGGACCAA GTACAAAGAA 480
CGTGGGGCGG AGGTGGGGAA GCTGGTGCAT GGCGTGGGGT GGAGGGGGGA GTGTCTGGGG 540
AAGGCTAGAG AGCAGAGCAT TAGACTCACA GAGACTGGGC CAGGGCTGAT TCTATTTCCC 600
AGAAGTCCAG ACTAAAATGA GGTTGGTTTG GGGAACTGAG AAGTTTCTCG CCCATCTTCA 660
GGGTTGATCA ATCATCAGTG AGGGACAAGA AATGACATGG GACAAGGCAA CAGATAGAAG 720
CTGGGAGCTA AACTTAGCTA TAACTGACAG AGCTGCTGCT ATCACATGGA GGGCCTCTAT 780
GCAAATTTTA AAAGGGCGGC CCTTCCTCTG GGCCATAGGC ATGCCCTGTG CCAGGCAGCC 840
CTGCTAACCT ATCCCATAGC TTATCTGTGC CCCCAATCCC TTTCTCGTCA TGCACTCCCC 900
AGTATGGGGT TGATGGGGAG TCTAGGTGAG TCCCGCGTCT 940
|
